Genfit S.A. (GNFT) Cash Flow Statement

The significant gap between net income and operating cash flow suggests that non-cash items and working capital fluctuations are masking the underlying cash-generative capacity of the business. Investors should monitor this relationship closely, as the inability to convert accounting milestones into consistent operating cash flow may indicate a reliance on external funding to bridge the gap.

The FCF margin volatility appears to be a direct consequence of the company's licensing-heavy business model, where cash inflows are tied to specific regulatory or clinical events rather than steady-state operations. This pattern suggests that the company's cash position is inherently fragile and susceptible to delays in the clinical pipeline.

These dramatic swings in working capital appear to be driven by the timing of milestone recognition and subsequent cash collection from partners. Such fluctuations make it difficult to assess the underlying operational burn rate, warranting further investigation into the company's cash conversion cycle and the reliability of its accounts receivable.